Read the New Results Blog
FDA Cracks Down on Compounded Semaglutide and Tirzepatide | What Patients Need to Know 1. Understanding the FDA’s Recent Actions The U.S. Food and Drug Administration (FDA) has recently intensified its oversight of compounded GLP-1 receptor agonists, specifically semaglutide and tirzepatide, which are commonly used for weight loss treatments. Compounded medications are custom-made drugs prepared by pharmacies to meet specific patient needs. However, the FDA has expressed concerns about the safety and
Long-Term Weight Maintenance with GLP-1 Injections in Scottsdale & Mesa 1. Understanding the Challenge of Sustained Weight Loss GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), have revolutionized weight loss by effectively suppressing appetite and improving metabolic health. However, maintaining weight loss after discontinuing these medications presents challenges. A recent analysis presented at the European Congress on Obesity found that individuals who stop taking GLP-1-based weight loss drugs typically regain the lost weight within a year.
Debunking Common Myths About GLP-1 Injections in Scottsdale & Mesa 1. Myth: GLP-1 Injections Are a Quick Fix for Weight Loss Fact: GLP-1 receptor agonists, such as semaglutide and tirzepatide, are effective tools for weight management but are most successful when combined with lifestyle changes. These medications mimic the GLP-1 hormone, which regulates appetite and insulin secretion, reducing hunger and improving blood sugar control. However, sustainable weight loss also requires dietary modifications, physical activity, and
1. Understanding the FDA’s Recent Actions The U.S. Food and Drug Administration (FDA) has recently intensified its oversight of compounded GLP-1 receptor agonists, specifically semaglutide and tirzepatide, which are commonly used for weight loss treatments. Compounded medications are custom-made drugs prepared by pharmacies to meet specific patient needs. However, the FDA has expressed concerns about the safety and efficacy of these unapproved versions. The
Hot Off The Press New Results Medical Weight Loss Announces Sarcotropin IPA Treatment Program FOR IMMEDIATE RELEASE Scottsdale, AZ, April 7, 2021 – New Results Medical Weight Loss is excited to announce the official launch of its Sarcotropin IPA Treatment Program, now available to clients across Arizona. Sarcotropin IPA, a pharmaceutical-grade peptide combination, is a revolutionary “medical food” designed to help maintain body integrity, promote fat loss, and maintain lean muscle mass in adults experiencing sarcopenia. This treatment offers a non-invasive
How Sarcotropin Encourages Weight Loss For years, the weight loss industry has promised quick fixes that claim to be the answer for everyone. But weight loss isn’t that simple, and it certainly isn’t the same for everyone. Fat loss, muscle mass, and metabolic changes all play different roles, and they require distinct approaches based on factors like age, gender, and activity levels. Did you know that after age 30, you can lose 3%-5% of your muscle mass every decade if you’re